Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
Study sponsor: BioAge Labs, Inc. · BIOA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-04-20Actual
Enrollment · participants194Actual
Source updated2023-07-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.